tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OPRX Stock Latest News

OptimizeRx Earnings Call: Strong Q3 and Upbeat Outlook
Company AnnouncementsOptimizeRx Earnings Call: Strong Q3 and Upbeat Outlook
1d ago
OPRX
OptimizeRx price target raised to $21 from $18 at Stifel
PremiumThe Fly
OptimizeRx price target raised to $21 from $18 at Stifel
2d ago
OPRX
OptimizeRx price target raised to $32 from $27 at Roth Capital
PremiumThe Fly
OptimizeRx price target raised to $32 from $27 at Roth Capital
2d ago
OPRX
OptimizeRx price target raised to $24 from $20 at Lake Street
PremiumThe Fly
OptimizeRx price target raised to $24 from $20 at Lake Street
2d ago
OPRX
OptimizeRx price target raised to $28 from $18 at B. Riley
PremiumThe Fly
OptimizeRx price target raised to $28 from $18 at B. Riley
2d ago
OPRX
OptimizeRx price target raised to $24 from $23 at Citizens JMP
PremiumThe FlyOptimizeRx price target raised to $24 from $23 at Citizens JMP
2d ago
OPRX
OptimizeRx Reports Strong Q3 Growth and Raises Guidance
Premium
Company Announcements
OptimizeRx Reports Strong Q3 Growth and Raises Guidance
2d ago
OPRX
OptimizeRx: Strong Financial Performance and Promising Outlook Justify Buy Rating
Premium
Ratings
OptimizeRx: Strong Financial Performance and Promising Outlook Justify Buy Rating
2d ago
OPRX
OptimizeRx reports Q3 EPS 20c, consensus 5c
PremiumThe Fly
OptimizeRx reports Q3 EPS 20c, consensus 5c
2d ago
OPRX
OptimizeRx raises FY25 revenue view to $105M-$109M from $104M-$108M
PremiumThe Fly
OptimizeRx raises FY25 revenue view to $105M-$109M from $104M-$108M
2d ago
OPRX
OptimizeRx sees FY26 revenue $118M-$124M, consensus $119.19M
PremiumThe Fly
OptimizeRx sees FY26 revenue $118M-$124M, consensus $119.19M
2d ago
OPRX
OPRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OPRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
OPRX
OptimizeRx price target raised to $23 from $20 at Citizens JMP
PremiumThe FlyOptimizeRx price target raised to $23 from $20 at Citizens JMP
30d ago
OPRX
OptimizeRx, Lamar Advertising announce strategic partnership
Premium
The Fly
OptimizeRx, Lamar Advertising announce strategic partnership
2M ago
LAMR
OPRX
OptimizeRx Announces Leadership Changes for Strategic Growth
Premium
Company Announcements
OptimizeRx Announces Leadership Changes for Strategic Growth
3M ago
8K
OPRX
OptimizeRx announces leadership team advancements
PremiumThe Fly
OptimizeRx announces leadership team advancements
3M ago
OPRX
OptimizeRx Earnings Call: Strong Growth and Positive Outlook
PremiumCompany Announcements
OptimizeRx Earnings Call: Strong Growth and Positive Outlook
3M ago
OPRX
OptimizeRx price target raised to $20 from $14 at Citizens JMP
PremiumThe Fly
OptimizeRx price target raised to $20 from $14 at Citizens JMP
3M ago
OPRX
OptimizeRx Reports Strong Q2 2025 Financial Growth
PremiumCompany Announcements
OptimizeRx Reports Strong Q2 2025 Financial Growth
3M ago
OPRX
OptimizeRx price target raised to $27 from $22 at Roth Capital
PremiumThe FlyOptimizeRx price target raised to $27 from $22 at Roth Capital
3M ago
OPRX
OptimizeRx: Strong Q2 Performance and Upgraded Guidance Justify Buy Rating
Premium
Ratings
OptimizeRx: Strong Q2 Performance and Upgraded Guidance Justify Buy Rating
3M ago
OPRX
OptimizeRx reports Q2 EPS 24c, consensus 2c
Premium
The Fly
OptimizeRx reports Q2 EPS 24c, consensus 2c
3M ago
OPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >